Judith Bouchardy
Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
Greutmann M, Tobler D, Engel R, Heg D, Mueller A, Frenk A, Gabriel H, Rutz T, Buechel R, Willhelm M, Trachsel L, Freese M, Ruperti-Repilado F, Valsangiacomo Buechel E, Beitzke D, Haaf P, Wustmann K, Schwitz F, Possner M, Schwitter J, Bouchardy J, Schwerzmann M, SERVE Investigators. Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE. Eur J Heart Fail 2023; 25:1105-1114.
13.06.2023Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
13.06.2023Eur J Heart Fail 2023; 25:1105-1114
Greutmann Matthias, Tobler Daniel, Engel Reto, Heg Dik, Mueller Arndt-Christian, Frenk André, Gabriel Harald, Rutz Tobias, Buechel Ronny Ralf, Willhelm Matthias, Trachsel Lukas, Freese Michael, Ruperti-Repilado Francisco Javier, Valsangiacomo Buechel Emanuela, Beitzke Dietrich, Haaf Philip, Wustmann Kerstin, Schwitz Fabienne, Possner Mathias, Schwitter Juerg, Bouchardy Judith, Schwerzmann Markus, SERVE Investigators
Patterns of Incidence Rates of Cardiac Complications in Patients With Congenital Heart Disease
Arslani K, Tobler D, Jost C, Ehl N, Rutz T, Bouchardy J, Schwerzmann M, Greutmann M, Zurek M, Roffler N, SACHER Investigators. Patterns of Incidence Rates of Cardiac Complications in Patients With Congenital Heart Disease. Can J Cardiol 2018; 34:1624-1630.
29.09.2018Patterns of Incidence Rates of Cardiac Complications in Patients With Congenital Heart Disease
29.09.2018Can J Cardiol 2018; 34:1624-1630
Arslani Ketina, Tobler Daniel, Jost Christine Attenhofer, Ehl Niklas, Rutz Tobias, Bouchardy Judith, Schwerzmann Markus, Greutmann Matthias, Zurek Marzena, Roffler Nico, SACHER Investigators